Psychiatry and Neurology, Neurology · Pensacola, FL
NPI
1689643645
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1110 Airport Blvd, Suite B
Pensacola, FL, 32504
Phone (850) 438-1136
Groups this clinician bills Medicare through
Medicare paid, 2024
$995K
107,831 services
Medicare patients, 2024
1,569
Average age 72
Drug cost, 2024
$4.7M
7,201 prescriptions
Company payments, 2025
$167K
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Bear was code J0585 (injection, onabotulinumtoxina, 1 unit), 62,601 times for 124 patients. In total David M Bear billed 107,831 services in 92 codes, and Medicare paid $995K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 62,601 | 124 | $4.66 | $292K |
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 13,000 | 23 | $13.73 | $179K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 12,950 | 31 | $3.97 | $51K |
| 99214 Office E&M - Established | Office | 778 | 532 | $86.12 | $67K |
| 95886 Electrical Nerve Conductivity | Office | 558 | 271 | $70.88 | $40K |
| 99213 Office E&M - Established | Office | 356 | 322 | $63.11 | $22K |
| 99215 Office E&M - Established | Office | 303 | 226 | $123.23 | $37K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 241 | 29 | $0.43 | $104 |
| 96375 Injection Administration | Office | 236 | 32 | $9.48 | $2,238 |
| 64615 Musculoskeletal | Office | 206 | 90 | $120.39 | $25K |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 175 | 32 | $0.82 | $143 |
| 70551 MRI/MRA - Head and Neck | Office | 173 | 172 | $143.41 | $25K |
| 95910 Electrical Nerve Conductivity | Office | 172 | 171 | $127.95 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 142 | 139 | $12.81 | $1,819 |
| 95874 Musculoskeletal | Office | 135 | 60 | $52.26 | $7,056 |
By year: 2022 $733K for 68,153 services; 2023 $889K for 89,161 services; 2024 $995K for 107,831 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Bear prescribed most often to Medicare patients was Gabapentin, with 536 prescriptions and refills. In total David M Bear wrote 7,201 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 536 | 874 | 137 | $8,152 |
| Pregabalin Generic | 417 | 599 | 89 | $10K |
| Donepezil Hcl Generic | 379 | 710 | 113 | $3,366 |
| Memantine Hcl Generic | 236 | 381 | 59 | $6,941 |
| Levetiracetam Generic | 220 | 386 | 44 | $8,136 |
| Topiramate Generic | 216 | 361 | 40 | $2,366 |
| Baclofen Generic | 212 | 347 | 58 | $2,614 |
| Clonazepam Generic | 196 | 257 | 35 | $1,570 |
| Emgality Pen Galcanezumab-Gnlm | 155 | 183 | 30 | $128K |
| Lamotrigine Generic | 154 | 269 | 36 | $3,459 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 152 | 290 | 43 | $4,837 |
| Duloxetine Hcl Generic | 151 | 238 | 35 | $2,935 |
| Rizatriptan Rizatriptan Benzoate | 128 | 168 | 41 | $2,054 |
| Qulipta Atogepant | 125 | 149 | 25 | $162K |
| Propranolol Hcl Generic | 117 | 252 | 35 | $2,605 |
Brand drugs: 1,454 claims; generic drugs: 5,716 claims; opioid claims: 227.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Bear $167K ($139K in general payments such as food, travel and fees and $27K for research) from 45 companies. The largest payer was Lilly USA, LLC with $87K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 71 | $87K |
| Ipsen Innovation IPN.PA | 8 | $27K |
| Abbvie Inc. ABBV | 68 | $19K |
| Pfizer Inc. PFE | 55 | $10K |
| Axsome Therapeutics, Inc. AXSM | 11 | $8,105 |
| Eli Lilly and Company LLY | 3 | $7,056 |
| Lundbeck LLC | 14 | $3,756 |
| Eisai Inc. 4523.T | 10 | $2,176 |
| Jazz Pharmaceuticals Inc. JAZZ | 14 | $375 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $184 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.